See All Slides - tctmd.com

Slides

Presentation TVT 2015

Procedural Considerations to Minimize PVR After TAVR: Valve Sizing and Postdilation

Presenter: David L. Brown

June 05, 2015

Presentation TVT 2015

CT Sizing for Other New TAVR Systems: Roundtable Discussion - Portico Valve

Presenter: Hasan Jilaihawi

June 05, 2015

Presentation TVT 2015

Thoughtful Commentary: Mild-Moderate Paravalvular Regurgitation During/After TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Howard C. Herrmann

June 05, 2015

Presentation TVT 2015

CT Sizing for Other New TAVR Systems: Roundtable Discussion - Lotus Valve

Presenter: Ian T. Meredith

June 05, 2015

Presentation TVT 2015

New Transapical Access Closure Devices

Presenter: Mani Arsalan, MD

June 05, 2015

Presentation TVT 2015

Case Presentation: Mild-Moderate Paravalvular Regurgitation During/After TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Torsten P. Vahl

June 05, 2015

Presentation TVT 2015

SAPIEN 3 Sizing Considerations: Oversizing, Undersizing, or Volume Reduction

Presenter: John G. Webb

June 05, 2015

Presentation TVT 2015

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Tamim Nazif

June 05, 2015

Presentation TVT 2015

New Transfemoral Access Closure Devices

Presenter: Eberhard Grube

June 05, 2015

Presentation TVT 2015

Thoughtful Commentary: AS and the Failing Bioprosthetic Mitral Valve

Presenter: Antonio Colombo, A. Pieter Kappetein, Neil E. Moat

June 05, 2015

Advertisement

Slides

Procedural Considerations to Minimize PVR After TAVR: Valve Sizing and Postdilation

CT Sizing for Other New TAVR Systems: Roundtable Discussion - Portico Valve

Thoughtful Commentary: Mild-Moderate Paravalvular Regurgitation During/After TAVR

CT Sizing for Other New TAVR Systems: Roundtable Discussion - Lotus Valve

New Transapical Access Closure Devices

Case Presentation: Mild-Moderate Paravalvular Regurgitation During/After TAVR

SAPIEN 3 Sizing Considerations: Oversizing, Undersizing, or Volume Reduction

Prevention and Management of Conduction Disturbances and Arrhythmias (AF) After TAVR

New Transfemoral Access Closure Devices

Thoughtful Commentary: AS and the Failing Bioprosthetic Mitral Valve

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content